Medication info
Glubiem Tablet 2/500 mg

Glubiem Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201106952 · Approved 2011.09.22 · Insurance code 652603030

Summary

Main use
Improves glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Improves glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps improve blood sugar control by using glymepiride and metformin in conjunction for patients with Type 2 diabetes. It assists in effectively managing blood sugar levels when used alongside dietary and exercise therapy. Hence, it is a suitable treatment option for Type 2 diabetes patients who require blood sugar management.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, if there is a sudden decrease in kidney function or signs of dehydration, it is necessary to temporarily discontinue use and consult a physician. It is not to be administered to patients with renal function less than 45 mL/min/1.73m2, severe hepatic impairment, pregnant or breastfeeding women. During the initial dosing period, the risk of hypoglycemia is increased, so careful monitoring of blood glucose changes is particularly necessary for patients in poor nutritional status or irregular eating patterns, elderly patients, and those consuming alcohol. While taking this medication, gastrointestinal disturbances (such as diarrhea, nausea, vomiting) may occur, which are usually temporary; however, if symptoms are severe, a physician should be consulted. If allergic reactions or symptoms of skin rash, hematological abnormalities occur, notify a physician immediately, as severe symptoms may require emergency treatment. Regularly check blood sugar control status, and if symptoms of hypoglycemia occur, immediately consume sugar to regain control. This medication can interact with various drugs; thus, it is essential to inform healthcare providers if you are taking other medications or starting new ones. In cases of acute infection, pre- and post-surgery, dehydration, severe trauma, etc., it may be necessary to temporarily discontinue this medication. During pregnancy or if planning to become pregnant, insulin therapy is recommended instead of this medication. It should be used cautiously in children and the elderly, with regular kidney function tests conducted to ensure there are no abnormalities. Overdosage can lead to hypoglycemia or lactic acidosis, so strictly adhere to the prescribed dosage, and seek immediate assistance from healthcare providers if abnormal symptoms arise.

Side effects

lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, pruritus, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, granulocytopenia, agranulocytosis, pancytopenia, peripheral neuropathy, megaloblastic anemia, increased liver enzymes, liver function damage, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, headache, severe hunger, fatigue, sleepiness, weakness, drowsiness, sleep disorder, instability, aggression, concentration deficit, attention deficit, abnormal response, depression, confusion, language disorder, aphasia, tremors, paralysis, sensory disturbance, dizziness, inability to self-regulate, delirium, cerebral convulsion, loss of consciousness, coma, weak breathing, slow pulse, sweating, moist skin, anxiety, rapid pulse, hypertension, palpitations, angina pectoris, deep vein thrombosis, dizziness, liver function abnormality, arthralgia, facial swelling, erectile dysfunction, flushing, gastritis, abdominal pain, abdominal distension, vomiting, dyspepsia, dizziness, palpitations, leg edema, cardiac arrest, rectal cancer, hypoglycemic coma, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. This method of storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.